Literature DB >> 20595497

Short course combination therapy for giardiasis after nitroimidazole failure.

Rogelio Lopez-Velez1, Carolina Batlle, Carolina Jiménez, Miriam Navarro, Francesca Norman, Jose Perez-Molina.   

Abstract

Recommended first line treatments for giardiasis include the nitroimidazoles and, recently, nitazoxanide. For refractory cases, a combination of two or more drugs may be a viable approach. A review of 10 patients with giardiasis refractory to nitroimidazoles with response to a short course (< 2 weeks), combined treatment is presented.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20595497      PMCID: PMC2912595          DOI: 10.4269/ajtmh.2010.09-0742

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  11 in total

1.  Treatment of patients with refractory giardiasis.

Authors:  T E Nash; C A Ohl; E Thomas; G Subramanian; P Keiser; T A Moore
Journal:  Clin Infect Dis       Date:  2001-05-23       Impact factor: 9.079

2.  Successful treatment of metronidazole- and albendazole-resistant giardiasis with nitazoxanide in a patient with acquired immunodeficiency syndrome.

Authors:  P Abboud; V Lemée; G Gargala; P Brasseur; J J Ballet; F Borsa-Lebas; F Caron; L Favennec
Journal:  Clin Infect Dis       Date:  2001-05-09       Impact factor: 9.079

Review 3.  A systematic review on the treatment of giardiasis.

Authors:  J O Zaat; T G Mank; W J Assendelft
Journal:  Trop Med Int Health       Date:  1997-01       Impact factor: 2.622

4.  Combined metronidazole and quinacrine hydrochloride therapy for chronic giardiasis.

Authors:  G D Taylor; W M Wenman; D L Tyrrell
Journal:  CMAJ       Date:  1987-06-01       Impact factor: 8.262

Review 5.  Treatment of giardiasis.

Authors:  T B Gardner; D R Hill
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

6.  Treatment of Giardiasis.

Authors:  William A Petri
Journal:  Curr Treat Options Gastroenterol       Date:  2005-02

7.  Albendazole as an alternative therapeutic agent for childhood giardiasis in Turkey.

Authors:  K Yereli; I C Balcioğlu; P Ertan; E Limoncu; A Onağ
Journal:  Clin Microbiol Infect       Date:  2004-06       Impact factor: 8.067

8.  Chronic giardiasis: studies on drug sensitivity, toxin production, and host immune response.

Authors:  P D Smith; F D Gillin; W M Spira; T E Nash
Journal:  Gastroenterology       Date:  1982-10       Impact factor: 22.682

Review 9.  Giardiasis: a pharmacotherapy review.

Authors:  Angel A Escobedo; Sergio Cimerman
Journal:  Expert Opin Pharmacother       Date:  2007-08       Impact factor: 3.889

10.  Treatment-ladder and genetic characterisation of parasites in refractory giardiasis after an outbreak in Norway.

Authors:  K Mørch; K Hanevik; L J Robertson; E A Strand; N Langeland
Journal:  J Infect       Date:  2008-03-07       Impact factor: 6.072

View more
  8 in total

Review 1.  Understanding drug resistance in human intestinal protozoa.

Authors:  Hend Aly El-Taweel
Journal:  Parasitol Res       Date:  2015-03-19       Impact factor: 2.289

2.  Frequency, diagnostic performance of coproantigen detection and genotyping of the Giardia among patients referred to a multi-level teaching hospital in northern India.

Authors:  Ujjala Ghoshal; Ratnakar Shukla; Priyannk Pant; Uday C Ghoshal
Journal:  Pathog Glob Health       Date:  2016-11-17       Impact factor: 2.894

3.  Treatment of giardiasis: current status and future directions.

Authors:  Richard R Watkins; Lars Eckmann
Journal:  Curr Infect Dis Rep       Date:  2014-02       Impact factor: 3.725

Review 4.  Efficacy of 5-nitroimidazoles for the treatment of giardiasis: a systematic review of randomized controlled trials.

Authors:  Vinay Pasupuleti; Angel Arturo Escobedo; Abhishek Deshpande; Priyaleela Thota; Yuani Roman; Adrian V Hernandez
Journal:  PLoS Negl Trop Dis       Date:  2014-03-13

Review 5.  Treatment-refractory giardiasis: challenges and solutions.

Authors:  Marco Lalle; Kurt Hanevik
Journal:  Infect Drug Resist       Date:  2018-10-24       Impact factor: 4.003

Review 6.  Selenium and protozoan parasitic infections: selenocompounds and selenoproteins potential.

Authors:  Sajad Rashidi; Celia Fernández-Rubio; Reza Mansouri; Mohammad Ali-Hassanzadeh; Esmaeel Ghani; Mohammadreza Karimazar; Raúl Manzano-Román; Paul Nguewa
Journal:  Parasitol Res       Date:  2022-01-06       Impact factor: 2.289

7.  High sensitivity of Giardia duodenalis to tetrahydrolipstatin (orlistat) in vitro.

Authors:  Juliane Hahn; Frank Seeber; Herbert Kolodziej; Ralf Ignatius; Michael Laue; Toni Aebischer; Christian Klotz
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240

8.  Acute Acalculous Cholecystitis Caused by Giardia lamblia.

Authors:  Hiromichi Araki; Shuya Shimizu; Katsumi Hayashi; Tomonori Yamada; Atsunori Kusakabe; Hiroshi Kanie; Yusuke Mizuno; Issei Kojima; Akitoshi Saitou; Kazuhiro Nagao; Yuka Suzuki; Tadashi Toyohara; Takanori Suzuki; Erika Uchida; Konomu Uno; Takahiro Nakazawa
Journal:  Intern Med       Date:  2017-07-01       Impact factor: 1.271

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.